| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 1998 American Heart Association, Inc.
Mini Review |
Application of Transcription Factor "Decoy" Strategy as Means of Gene Therapy and Study of Gene Expression in Cardiovascular Disease
From the Department of Geriatric Medicine, Osaka University Medical School, Suita, Japan.
Correspondence to Toshio Ogihara, MD, PhD, Professor of Medicine, Department of Geriatric Medicine, Osaka University Medical School, 2-2 Yamada-oka, Suita, Osaka 565, Japan.
Abstract
Abstract—Recent progress in molecular biology has provided new techniques for inhibiting target gene expression. In particular, the application of DNA technology, such as antisense strategy to regulate the transcription of disease-related genes in vivo, has important therapeutic potential. Recently, transfection of cis-element double-stranded oligodeoxynucleotides (ODNs), referred to as "decoy" ODNs, has been reported to be a powerful tool in a new class of anti-gene strategies for gene therapy and in the study of transcriptional regulation. Transfection of double-stranded ODNs corresponding to the cis sequence will result in the attenuation of authentic cis-trans interaction, leading to the removal of trans factors from the endogenous cis elements with subsequent modulation of gene expression. This "decoy" strategy is not only a novel strategy for gene therapy as an anti-gene strategy but also a powerful tool for the study of endogenous gene regulation in vivo as well as in vitro. In this article, we reviewed (1) the mechanisms and (2) the potential applications of decoy strategy.
Key Words: cis-element decoy • restenosis • myocardial infarction • glomerulonephritis • gene regulation
This article has been cited by other articles:
 |
|
 |
|
  S. M. Fennewald, E. P. Scott, L. Zhang, X. Yang, J. F. Aronson, D. G. Gorenstein, B. A. Luxon, R. E. Shope, D. W. C. Beasley, A. D. T. Barrett, et al. Thioaptamer decoy targeting of AP-1 proteins influences cytokine expression and the outcome of arenavirus infections J. Gen. Virol., March 1, 2007; 88(3): 981 - 990. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Ohtani, K. Egashira, K. Nakano, G. Zhao, K. Funakoshi, Y. Ihara, S. Kimura, R. Tominaga, R. Morishita, and K. Sunagawa Stent-Based Local Delivery of Nuclear Factor-{kappa}B Decoy Attenuates In-Stent Restenosis in Hypercholesterolemic Rabbits Circulation, December 19, 2006; 114(25): 2773 - 2779. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Morishita, M. Aoki, and T. Ogihara Does gene therapy become pharmacotherapy? Exp Physiol, May 1, 2005; 90(3): 307 - 313. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. N. Thatcher, S. Peddada, D. H. Yasui, and J. M. LaSalle Homologous pairing of 15q11-13 imprinted domains in brain is developmentally regulated but deficient in Rett and autism samples Hum. Mol. Genet., March 15, 2005; 14(6): 785 - 797. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Zhang, J. Zhang, C. Y. F. Young, P. C. Kao, W. Chen, A. Jiang, L. Zhang, and Q. Guo Decoy Androgen-Responsive Element DNA Can Inhibit Androgen Receptor Transactivation of the PSA Promoter Gene Ann. Clin. Lab. Sci., January 1, 2005; 35(3): 278 - 284. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Bene, R. C. Kurten, and T. C. Chambers Subcellular localization as a limiting factor for utilization of decoy oligonucleotides Nucleic Acids Res., October 21, 2004; 32(19): e142 - e142. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Cattaruzza, T. J. Guzik, W. Slodowski, A. Pelvan, J. Becker, M. Halle, A. B. Buchwald, K. M. Channon, and M. Hecker Shear Stress Insensitivity of Endothelial Nitric Oxide Synthase Expression as a Genetic Risk Factor for Coronary Heart Disease Circ. Res., October 15, 2004; 95(8): 841 - 847. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Crinelli, M. Bianchi, L. Gentilini, L. Palma, M. D. Sorensen, T. Bryld, R. B. Babu, K. Arar, J. Wengel, and M. Magnani Transcription factor decoy oligonucleotides modified with locked nucleic acids: an in vitro study to reconcile biostability with binding affinity Nucleic Acids Res., March 29, 2004; 32(6): 1874 - 1885. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Woods, E. G. Wood, S. C. Bardswell, D. Bishop-Bailey, S. Barker, S. J. Wort, J. A. Mitchell, and T. D. Warner Role for Nuclear Factor-{kappa}B and Signal Transducer and Activator of Transcription 1/Interferon Regulatory Factor-1 in Cytokine-Induced Endothelin-1 Release in Human Vascular Smooth Muscle Cells Mol. Pharmacol., October 1, 2003; 64(4): 923 - 931. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Taylor and C. A. McNamara Regulation of Vascular Smooth Muscle Cell Growth: Targeting the Final Common Pathway Arterioscler. Thromb. Vasc. Biol., October 1, 2003; 23(10): 1717 - 1720. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Cattaruzza, W. Slodowski, M. Stojakovic, R. Krzesz, and M. Hecker Interleukin-10 Induction of Nitric-oxide Synthase Expression Attenuates CD40-mediated Interleukin-12 Synthesis in Human Endothelial Cells J. Biol. Chem., September 26, 2003; 278(39): 37874 - 37880. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Sun, S. Palmqvist, H. Olsson, M. Boren, S. Ahlandsberg, and C. Jansson A Novel WRKY Transcription Factor, SUSIBA2, Participates in Sugar Signaling in Barley by Binding to the Sugar-Responsive Elements of the iso1 Promoter PLANT CELL, September 1, 2003; 15(9): 2076 - 2092. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. von Knethen and B. Brune Activation of Peroxisome Proliferator-Activated Receptor {gamma} by Nitric Oxide in Monocytes/Macrophages Down-Regulates p47phox and Attenuates the Respiratory Burst J. Immunol., September 1, 2002; 169(5): 2619 - 2626. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Crinelli, M. Bianchi, L. Gentilini, and M. Magnani Design and characterization of decoy oligonucleotides containing locked nucleic acids Nucleic Acids Res., June 1, 2002; 30(11): 2435 - 2443. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. H. Wagner, M. Gebauer, B. Pollok-Kopp, and M. Hecker Cytokine-inducible CD40 expression in human endothelial cells is mediated by interferon regulatory factor-1 Blood, January 15, 2002; 99(2): 520 - 525. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. P. Liu, J. Le, and M. Nian Nuclear Factor-{kappa}B Decoy: Infiltrating the Heart of the Matter in Inflammatory Heart Disease Circ. Res., November 9, 2001; 89(10): 850 - 852. [Full Text] [PDF]
|
|
|
|
 |
|
 Z.-Z. Yang and A.-P. Zou Transcriptional regulation of heme oxygenases by HIF-1alpha in renal medullary interstitial cells Am J Physiol Renal Physiol, November 1, 2001; 281(5): F900 - F908. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. H. Wagner, R. Krzesz, D. Gao, C. Schroeder, M. Cattaruzza, and M. Hecker Decoy Oligodeoxynucleotide Characterization of Transcription Factors Controlling Endothelin-B Receptor Expression in Vascular Smooth Muscle Cells Mol. Pharmacol., April 13, 2001; 58(6): 1333 - 1340. [Abstract] [Full Text]
|
|
|
|
|
|
R. Morishita Adventure of Gene Therapy Into the Brain: A New Era for Cardiovascular Gene Therapy Circ. Res., October 27, 2000; 87(9): 719 - 721. [Full Text] [PDF]
|
|
|
|
|
|
S. Kitamoto, K. Egashira, C. Kataoka, M. Koyanagi, M. Katoh, H. Shimokawa, R. Morishita, Y. Kaneda, K. Sueishi, and A. Takeshita Increased Activity of Nuclear Factor-{kappa}B Participates in Cardiovascular Remodeling Induced by Chronic Inhibition of Nitric Oxide Synthesis in Rats Circulation, August 15, 2000; 102(7): 806 - 812. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Matsushita, R. Morishita, T. Nata, M. Aoki, H. Nakagami, Y. Taniyama, K. Yamamoto, J. Higaki, K. Yasufumi, and T. Ogihara Hypoxia-Induced Endothelial Apoptosis Through Nuclear Factor-{kappa}B (NF-{kappa}B)-Mediated bcl-2 Suppression : In Vivo Evidence of the Importance of NF-{kappa}B in Endothelial Cell Regulation Circ. Res., May 12, 2000; 86(9): 974 - 981. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. C. Hess, E. Howard, C. Cheng, J. Carroll, W. D. Hill, and C. Y. Hsu Hypertonic Mannitol Loading of NF-{kappa}B Transcription Factor Decoys in Human Brain Microvascular Endothelial Cells Blocks Upregulation of ICAM-1 Editorial Comment Stroke, May 1, 2000; 31(5): 1179 - 1186. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. H. Wang, X. Y. Yang, R. A. Kirken, J. H. Resau, and W. L. Farrar Targeted disruption of Stat6 DNA binding activity by an oligonucleotide decoy blocks IL-4-driven TH2 cell response Blood, February 15, 2000; 95(4): 1249 - 1257. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. O Hiltunen, M. P Turunen, M. Laitinen, and S. Yla-Herttuala Insights into the molecular pathogenesis of atherosclerosis and therapeutic strategies using gene transfer Vascular Medicine, February 1, 2000; 5(1): 41 - 48. [Abstract] [PDF]
|
|
|
|
 |
|
 A. Dobi, M. Palkovits, C. G. Palkovits, M. A. Ring, and D. v. Agoston Septamer Element-Binding Proteins in Neuronal and Glial Differentiation J. Neurosci., February 1, 2000; 20(3): 1073 - 1084. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Sinnaeve, O. Varenne, D. Collen, and S. Janssens Gene therapy in the cardiovascular system: an update Cardiovasc Res, December 1, 1999; 44(3): 498 - 506. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Kupatt, H. Habazettl, A. Goedecke, D. A. Wolf, S. Zahler, P. Boekstegers, R. A. Kelly, and B. F. Becker Tumor Necrosis Factor-{alpha} Contributes to Ischemia- and Reperfusion-Induced Endothelial Activation in Isolated Hearts Circ. Res., March 5, 1999; 84(4): 392 - 400. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Cattaruzza, I. Eberhardt, and M. Hecker Mechanosensitive Transcription Factors Involved in Endothelin B Receptor Expression J. Biol. Chem., September 28, 2001; 276(40): 36999 - 37003. [Abstract] [Full Text] [PDF]
|
|